Teva Pharmaceutical Industries reported $959M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
Aspen Pharmacare ZAR 5.37B 230M Dec/2024
Cipla INR 13.12B 792M Jun/2025
Dr.Reddys Laboratories INR 25.65B 10.39B Jun/2025
Guangzhou Baiy CNY 2.04B 246.81M Jun/2025
Jiangsu Hengrui CNY 3.12B 575.34M Jun/2025
Kalbe Farma IDR 2.1T 312.21B Jun/2025
Richter Gedeon HUF 51.12B 4.36B Sep/2024
Sh Fosun Pharma CNY 3.14B 30.87M Jun/2025
Sun Pharmaceuticals INR 24.89B 637.6M Mar/2025
Teva Pharmaceutical Industries USD 959M 40M Jun/2025